Brief: Neurizon Therapeutics Says US Patent Granted For NUZ-001
05/02/2025 01:19
Feb 5 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX :
* US PATENT GRANTED FOR NUZ-001 FOR TREATMENT OF
NEURODEGENERATIVE
DISEASES
Further company coverage: NUZ.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility